3-[211At]astato-4-fluorobenzylguanidine: A potential therapeutic agent with prolonged retention by neuroblastoma cells

British Journal of Cancer

Volumn 76, Issue 2, 1997, Pages 226-233

  Vaidyanathan, G ^a   Zhao, X G ^a   Larsen, R H ^a   Zalutsky, M R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

3 211At astato 4 fluorobenzylguanidine; Meta iodobenzylguanidine; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; DESIPRAMINE; NORADRENALIN; OUABAIN; RADIOPHARMACEUTICAL AGENT; (4 FLUORO 3 IODOBENZYL)GUANIDINE; (4-FLUORO-3-IODOBENZYL)GUANIDINE; 1 (3 ASTATOBENZYL)GUANIDINE; 1-(3-ASTATOBENZYL)GUANIDINE; ASTATINE; GUANIDINE DERIVATIVE; IODOBENZENE; RADIOACTIVE IODINE;

ARTICLE; DRUG RETENTION; DRUG UPTAKE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; BINDING SITE; CELL CULTURE; CHEMISTRY; MALE; METABOLISM; MOUSE; NEUROBLASTOMA; TISSUE DISTRIBUTION;

3-IODOBENZYLGUANIDINE; ANIMALS; ANTINEOPLASTIC AGENTS; ASTATINE; BINDING SITES; GUANIDINES; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MICE; MICE, INBRED BALB C; NEUROBLASTOMA; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0030611579     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.366     Document Type: Article

References (27)

1. Barnette WE (1984) The synthesis and biology of fluorinated prostacyclins. CRC Critical Rev Biochem 15: 201-235
2. Biedler JN, Helson I. and Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652
3. 125]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res 45: 6366-6370
4. Garaventa A, Guerra P, Arrighini A, Bertolazzi L, Bestagno M, De Bernardi B, Lanino E, Villavecchia GP and Claudiani F (1991) Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine. Cancer 67: 922-928
5. 2 fragment. Cancer Res 50: 3514-3520
6. 131I]-metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of an innovative strategy for advanced neuroblastoma. Eur J Cancer 31A: 252-256
7. Goldman P (1969) The carbon-fluorine bond in compounds of biological interest. Science 164: 1123-1130
8. Kemshead JT, Pizer PL and Patel K (1990) Neuroblastoma: Perspectives for future research. In Neuroblastoma: Tumor Biology and Therapy. Pochedly C (ed.), pp 381-395. CRC Press: Boca Raton, FL
9. 131I]-Metaiodobenzylguanidine in the treatment of metaslatic neuroblastoma. Clinical, pharmacological and dosimetric aspects. Cancer Chemother Pharmacol 25: 143-148
10. 211At reaction. Appl Radiat Isot 47: 135-143
11. Mangner TJ, Tobes MC, Wieland DW, Sisson JC and Shapiro B (1986) Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma. J Nucl Med 27: 37-44
12. Mairs R, Angerson WJ, Babich JW and Murray T (1991) Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma. In Advances in Neuroblastoma Research 3, Prog. Clin. Biol. Res. Vol. 366, Evans AE, D'Angio GJ, Knudson Jr AG, and Seeger RC (eds), pp. 495-501. Wiley-Liss: New York
13. 131I-radiolabelled meta-iodobenzylguanidine (MIBG) for the targeted radiotherapy of neuroblastoma. Br J Radiol 64: 428-434
14. 125I]meta-iodobenzylguanidine in neuroblastoma cells: Evidence of a carrier-mediated efflux. Eur J Cancer 31A: 591-595
15. 123I-MIBG. Med Pediatr Oncol 15: 170-177
16. Sisson JC, Hutchinson RJ, Shapiro B, Zasadny KR, Normolle D, Wieland DM, Wahl RL, Singer DA, Mallete SA and Mudgett EE (1990) Iodine-125-MIBG to treat neuroblastoma: Preliminary report. J Nucl Med 31: 1479-1485
17. Smets LA, Loesberg C, Janssen M, Metwally EA and Huiskamp R (1989) Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res 49: 2941-2944
18. 211At]astatobenzylguanidine on human neuroblastoma cells. Cancer Res 54: 5414-5419
19. 211At]Astatobenzyl)guanidine: Synthesis via astato demetalation and preliminary in vitro and in vivo evaluation. Bioconjugate Chem 3: 499-503
20. 131I]-iodobenzylguanidine. Appl Radiat Isot 44: 621-628
21. 211At]astatobenzylguanidine: Further evaluation of a potential therapeutic agent. Int J Cancer 57: 908-913
22. 18F]Fluoro-3-iodobenzylguanidine: A potential MIBG analog for positron emission tomography. J Med Chem 37: 3655-3662
23. 18F]fluoro-3-iodobenzylguanidine as a potential PET analog of MIBG. J Nucl Med 36: 644-650
24. 211At]astato-4-fluorobenzylguanidine. Bioconjugate Chem 7: 102-107
25. 131I]iodobenzylguanidine: An MIBG analogue with improved binding to neuroblastoma cells in vitro and myocardial retention in vivo. J Nucl Med 38: 330-334
26. Valette H, Loc'h C, Mardon K, Bendriem B, Merlet P, Fuseau C, Sabry S, Raffel D, Mazière B and Syrota A (1993) Bromine-76-metabromobenzylguanidine: A PET radiotracer for mapping sympathetic nerves of the heart. J Nucl Med 34: 1739-1744
27. 2 fragments with the alpha particle emitting nuclide astatine-211: Preservation of immunoreactivity and in vivo localizing capacity. Proc Natl Acad Sci USA 86: 7149-7153